New York A 500: Establishes a generic drug research and development laboratory and production facility and the empire state biosimilar insulin initiative

Status: REFERRED TO HEALTH (as of 2026-01-07)

State: New York · Session: 2025-2026 · Bill: A 500

Sponsors: Phil Steck

View New York A 500 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.